Fosnetupitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Short Review and Clinical Perspective.

Adv Ther · 2023 · PMC10129973 · PMID 36884027

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

a favorable trendP = 0.071so close (0.05 < p ≤ 0.1)

Also, Kaplan–Meier curves for time to treatment failure (i.e., time to first emetic event or use of rescue medication) showed a separation after 96 h, with a favorable trend in the fosnetupitant group (hazard ratio 0.789; 95% CI 0.610, 1.021; P = 0.071).

also in 313 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.